Home Tags CM – Allakos reports data from studies on late-stage eosinophilic gastrointestinal diseases
Tag: CM – Allakos reports data from studies on late-stage eosinophilic gastrointestinal diseases
Allakos (ALLK) announces data from ENIGMA 2, a 24-week phase 3 study of lirentelimab in patients with biopsy-confirmed eosinophilic gastritis and / or eosinophilic duodenitis and KRYPTOS, ...